Two of the world's
A sector of the pharmaceutical market known as "high-margin specialty drugs" is presenting us with the best pharmaceutical stocks to buy now....
Editor's Note: We're sharing this Private Briefing with you because it contains a pick that's put Bill's readers up as much as 444%...
Pharmaceutical stocks can plummet for myriad reasons: loss of funding, lawsuits, poor clinical trials.
It's a risky sector to get...
Antibiotic-resistant microorganisms are turning into a national medical nightmare, and the need for new, more effective...
Pharmaceutical stocks soar when their companies receive FDA approval. The key to investing in the pharmaceutical sector is research: you've got...
There are more than 1,000 biotech companies in North America alone. They cover a wide range of sectors including pharmaceuticals, biologics,...
It's a common thought that investing in biotech stocks is just too risky for the average investor - but that's not the case.
It's true...
Investing in biotech stocks is risky for those who haven't done enough research. But with just a couple of tips, investors can drastically...
Ask any bioscience researcher about leading trends in medical science, and at some point, you're likely to hear a lot of...
Biogen Idec Inc. (Nasdaq: BIIB) stock was up 1.6% this morning following news that the company's multiple sclerosis (MS) drug...
One of yesterday's (Wednesday) biggest stock gainers, Cerulean Pharma Inc. (Nasdaq: CERU), was a biotech company, posting an 30.6% gain by day's...
Best stocks to buy for the week ending July 4, 2014: Last week, we covered a "catalyst" that could spark a share-price...
When looking for the best pharmaceutical stocks to buy, investors often search for companies making breakthrough discoveries, completing...
With just six months left on my 2014 bioscience "profit calendar," things are really starting to look promising for the second...
IPO Calendar 2014 update: This year, 212 companies have already held IPOs, and the healthcare industry has seen more companies...
At first glance, it may seem like bioscience investing is so complicated and risky that it's hardly worth your time and money to invest, at least if...
Vertex Pharmaceuticals Inc. (Nasdaq:
Each week our Money Morning experts dish out the latest profit plays - and asset-protection moves - for our...
When Valeant Pharmaceuticals International Inc. (NYSE: VRX) and activist investor Bill Ackman made an unsolicited $46 billion...